Impact of obesity on treatment of chronic hepatitis C†
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 43 (6), 1177-1186
- https://doi.org/10.1002/hep.21239
Abstract
Obesity and the metabolic syndrome have hepatic manifestations, including steatosis and progression of fibrosis. In individuals with chronic hepatitis C, obesity is associated with inflammation, insulin resistance, steatosis, progression of fibrosis, and nonresponse to treatment with interferon or peginterferon alpha and ribavirin. Patients with both hepatitis C and obesity‐related nonalcoholic fatty liver disease are at greater risk for more advanced liver disease. We review the mechanisms by which obesity may be associated with decreased efficacy of interferon‐based therapies in individuals with chronic hepatitis C and the therapeutic strategies that may increase the effectiveness of these therapies in obese individuals. (HEPATOLOGY 2006;43: 1177–1186.)Keywords
This publication has 117 references indexed in Scilit:
- Adiponectin and its receptors in patients with chronic hepatitis CJournal of Hepatology, 2005
- 610 Anti IL-6 therapy rescues transgenic mice with liver specific overexpression of TGF-β1 from death after LPS mediated liver injuryJournal of Hepatology, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsJournal of Hepatology, 2004
- Identification of A Ribavirin–Resistant Ns5b Mutation of Hepatitis C Virus During Ribavirin MonotherapyHepatology, 2003
- Effect of Treatment With Peginterferon or Interferon Alfa–2B and Ribavirin on Steatosis in Patients Infected With Hepatitis CHepatology, 2003
- Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis CGut, 2002
- Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob miceHepatology, 2002
- Road signs guiding leukocytes along the inflammation superhighwayJournal of Allergy and Clinical Immunology, 2000
- Non-organ specific autoantibodies in children with chronic hepatitis CJournal of Hepatology, 1996